Intra-individual genomic diversity between circulating tumor cell-free DNA (cfDNA) and tumor tissue testing in metastatic renal cell carcinoma (mRCC).

被引：0
|
作者：
Hahn, Andrew W.
Gill, David Michael
Streeter, Jessica
Bailey, Erin B.
Carroll, Emma
Aryal, Lubina
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 06期
关键词：
D O I：
10.1200/JCO.2017.35.6_suppl.444
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
444
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Genomic diversity between primary tumor tissue and tumor circulating cell-free DNA (cfDNA) in patients (pts) with metastatic prostate cancer.
    Carroll, Emma
    Gill, David Michael
    Poole, Austin
    Hahn, Andrew W.
    Bailey, Erin B.
    Streeter, Jessica
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [2] Cell-free Circulating Tumor DNA (ctDNA) in Metastatic Renal Cell Carcinoma (mRCC): Current Knowledge and Potential Uses
    Hahn, Andrew W.
    Nussenzveig, Roberto H.
    Maughan, Benjamin L.
    Agarwal, Neeraj
    KIDNEY CANCER, 2019, 3 (01) : 7 - 13
  • [3] Assessment of circulating cell-free tumor DNA (ctDNA) in 847 patients (pts) with metastatic renal cell carcinoma (mRCC) and concordance with tissue-based testing
    Zengin, Z. B.
    Weipert, C.
    Hsu, J.
    Salgia, N.
    Saam, J.
    Choueiri, T. K.
    Agarwal, N.
    Pal, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S553 - S554
  • [4] Circulating Cell-Free Tumor DNA (cfDNA) Testing in Small Cell Lung Cancer
    Morgensztern, Daniel
    Devarakonda, Siddhartha
    Masood, Ashiq
    Waqar, Saiama
    Carmack, Alicia
    Banks, Kimberly
    Lanman, Richard
    Govindan, Ramaswamy
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S717 - S718
  • [5] Circulating cell-free tumor DNA (cfDNA) testing in small cell lung cancer.
    Morgensztern, Daniel
    Devarakonda, Siddhartha H. K.
    Masood, Ashiq
    Waqar, Saiama Naheed
    Carmack, Alicia C.
    Banks, Kimberly C.
    Lanman, Richard Burnham
    Govindan, Ramaswamy
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Association of circulating tumor DNA (ctDNA) detection in metastatic renal cell carcinoma (mRCC) with tumor burden
    Maia, Manuel Caitano
    Bergerot, Paulo Gustavo
    Dizman, Nazli
    Hsu, Joann
    Jones, Jeremy
    Choueiri, Toni K.
    Sonpavde, Guru
    Lannnan, Richard B.
    Banks, Kimberly
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Circulating tumor DNA sequencing analysis of patients with metastatic renal cell carcinoma (mRCC).
    Zengin, Zeynep Busra
    Dizman, Nazli
    Salgia, Nicholas
    Jones, Jeremy
    Zhang, Jingbo
    Liu, Yunchao
    Xu, Bing
    Li, Fuwei
    Wang, Yan
    Li, Mengjian
    Du, Rong
    Zhou, Ye
    Hsu, Joann
    Salgia, Meghan
    Yang, Lixin
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Complementary Role of Circulating Tumor DNA Assessment and Tissue Genomic Profiling in Metastatic for Renal Cell Carcinoma
    Zengin, Zeynep B.
    Weipert, Caroline
    Salgia, Nicholas J.
    Dizman, Nazli
    Hsu, Joann
    Meza, Luis
    Chehrazi-Raffle, Alexander
    Muddasani, Ramya
    Salgia, Sabrina
    Malhotra, Jasnoor
    Chawla, Neal
    Philip, Errol J.
    Kiedrowski, Lesli
    Maughan, Benjamin L.
    Rathi, Nityam
    Goel, Divyam
    Choueiri, Toni K.
    Agarwal, Neeraj
    Pal, Sumanta K.
    CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4807 - 4813
  • [9] Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell Carcinoma
    Basu, Arnab
    Au, Cherry
    Kommalapati, Ajitha
    Kandala, Hyndavi
    Sudhaman, Sumedha
    Mahmood, Tamara
    Carson, Carcia
    Pajak, Natalia
    Dutta, Punashi
    Calhoun, Mark
    Malhotra, Meenakshi
    Elnaggar, Adam C.
    Liu, Minetta C.
    Ferguson Iii, James
    Peyton, Charles
    Rais-Bahrami, Soroush
    Tan, Alan
    JCO PRECISION ONCOLOGY, 2024, 8
  • [10] Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC).
    Zurita, Amado J.
    Danziger, Natalie
    Scott, Takara
    Gjoerup, Ole
    Zhong, Lei
    Tukachinsky, Hanna
    Ross, Jeffrey S.
    Graf, Ryon
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 455 - 455
12345